Monroe Capital acted as sole lead arranger and administrative agent on the funding of a senior credit facility to support the acquisition of ProPharma Group by private equity sponsor, Linden Capital Partners.

Overland Park, KS-based ProPharma is a provider of outsourced medical information, pharmacovigilance and regulatory compliance consulting services to customers in the pharmaceutical, biotechnology and medical device industries. The company operates five contact centers across the U.S., Europe and Australia.